María José Villanueva Silva
University Hospital Complex Of Vigo(ES)
Publications by Year
Research Areas
Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107).(2021)35 cited
- → An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores(2022)4 cited
- → Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cáncer (NS-NSCLC). A Galician Lung Cancer Group Study.(2015)1 cited
- → Study of the usefulness of angiotensin type 1 receptor (AGTR1) as a possible response predictor in patients with metastatic breast cancer (mBC) subjected to chemotherapy and treatment with bevacizumab (AVALUZ Study).(2012)1 cited
- → AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis.(2012)1 cited
- → Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.(2019)1 cited
- → Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer(2022)
- → GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).(2012)
- → Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)(2026)
- → Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study.(2012)